Market Cap 421.75M
Revenue (ttm) 154.01M
Net Income (ttm) -308.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -200.41%
Debt to Equity Ratio 0.00
Volume 13,111,500
Avg Vol 11,352,232
Day's Range N/A - N/A
Shares Out 273.86M
Stochastic %K 34%
Beta 1.92
Analysts Sell
Price Target $2.75

Latest News on PACB

PacBio Grants Equity Incentive Award to New Employee

Feb 14, 2025, 11:09 PM EST - 8 days ago

PacBio Grants Equity Incentive Award to New Employee


Trump's Cuts to Medical Research Are Hurting These Stocks

Feb 12, 2025, 7:19 PM EST - 10 days ago

Trump's Cuts to Medical Research Are Hurting These Stocks

ILMN TXG


Pacific Biosciences' Cost Cuts Won't Offset Rising Competition

Nov 12, 2024, 3:38 PM EST - 3 months ago

Pacific Biosciences' Cost Cuts Won't Offset Rising Competition


PacBio to Present at Upcoming Investor Conferences

Nov 8, 2024, 4:05 PM EST - 3 months ago

PacBio to Present at Upcoming Investor Conferences